Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
GTES
|
Walter Lifsey
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 12,072 Added 7.98% |
-
|
Feb 28
2022 |
|
GTES
|
Lawrence B Mallard
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,274 Reduced 10.56% |
$35,838
$15.76 p/Share
|
Feb 28
2022 |
|
GTES
|
Lawrence B Mallard
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,854 Added 26.72% |
-
|
Feb 28
2022 |
|
GTES
|
Terry A Klebe
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 6 Reduced 0.01% |
$95
$15.76 p/Share
|
Feb 28
2022 |
|
GTES
|
Wilson S Neely
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 6 Reduced 0.02% |
$95
$15.76 p/Share
|
Feb 28
2022 |
|
GTES
|
James W Ireland
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 6 Reduced 0.02% |
$95
$15.76 p/Share
|
Feb 28
2022 |
|
MMLP
|
Ruben S Martin
Director |
BUY
Open market or private purchase
|
Indirect | 47,740 Added 1.74% |
$152,291
$3.19 p/Share
|
Feb 28
2022 |
|
AMN
|
Susan R Salka
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 22,475 Reduced 83.5% |
$2,404,825
$107.0 p/Share
|
Feb 28
2022 |
|
RUTH
|
Giannella Alvarez
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,585 Added 11.81% |
-
|
Feb 28
2022 |
|
RUTH
|
Michael P Odonnell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,585 Added 0.53% |
-
|
Feb 28
2022 |
|
RUTH
|
Stephen M King
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,585 Added 16.25% |
-
|
Feb 28
2022 |
|
RUTH
|
Mary Baglivo
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,585 Added 14.12% |
-
|
Feb 28
2022 |
|
SNPS
|
John F Runkel Jr
GC & Corporate Secretary |
BUY
Other acquisition or disposition
|
Direct | 52 Added 0.23% |
$9,960
$191.54 p/Share
|
Feb 28
2022 |
|
RTL
|
Stanley R Perla
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 11.21% |
$70,600
$7.06 p/Share
|
Feb 28
2022 |
|
CLOQ
|
Christopher S. Jackson
President |
BUY
Grant, award, or other acquisition
|
Direct | 100,000 Added 1.67% |
-
|
Feb 28
2022 |
|
CLOQ
|
Enrico Giordano
Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 100,000 Added 1.82% |
-
|
Feb 28
2022 |
|
CLOQ
|
Mark Carten
Chief Technical Officer |
SELL
Other acquisition or disposition
|
Direct | 500,000 Reduced 9.26% |
$50,000
$0.1 p/Share
|
Feb 28
2022 |
|
CLOQ
|
Mark Carten
Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 100,000 Added 1.82% |
-
|
Feb 28
2022 |
|
CLOQ
|
Mark Carten
Chief Technical Officer |
SELL
Other acquisition or disposition
|
Direct | 10,000 Reduced 100.0% |
-
|
Feb 28
2022 |
|
NTWK
|
Najeeb Ghauri
CEO |
BUY
Open market or private purchase
|
Direct | 3,000 Added 0.37% |
$12,000
$4.0 p/Share
|
Feb 28
2022 |
|
UTGN
|
Douglas Paul Ditto
Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 6,457 Added 13.49% |
-
|
Feb 28
2022 |
|
UTGN
|
James Patrick Rousey
President |
BUY
Grant, award, or other acquisition
|
Direct | 1,845 Added 12.34% |
-
|
Feb 28
2022 |
|
UTGN
|
Theodore Clayton Miller
Senior Vice President and CFO |
BUY
Grant, award, or other acquisition
|
Direct | 1,000 Added 7.0% |
-
|
Feb 28
2022 |
|
UTGN
|
Casey Jonathan Willis
Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 1,200 Added 16.61% |
-
|
Feb 28
2022 |
|
EDF
|
Heath B Mclendon |
BUY
Open market or private purchase
|
Direct | 500 Added 5.87% |
$3,055
$6.11 p/Share
|
Feb 28
2022 |
|
HHS
|
David L Copeland
Director |
BUY
Open market or private purchase
|
Direct | 15,000 Added 15.54% |
$98,400
$6.56 p/Share
|
Feb 28
2022 |
|
HHS
|
Robert T. Wyman
General Counsel |
BUY
Open market or private purchase
|
Direct | 750 Added 2.68% |
$4,867
$6.49 p/Share
|
Feb 28
2022 |
|
HHS
|
Brian Linscott
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 34,100 Added 9.06% |
$223,355
$6.55 p/Share
|
Feb 28
2022 |
|
LXRX
|
Lonnel Coats
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 48,053 Reduced 7.58% |
$136,951
$2.85 p/Share
|
Feb 28
2022 |
|
LXRX
|
Lonnel Coats
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 197,343 Added 23.74% |
-
|
Feb 28
2022 |
|
LXRX
|
Jeffrey L Wade
President and COO |
SELL
Payment of exercise price or tax liability
|
Direct | 25,773 Reduced 11.74% |
$73,453
$2.85 p/Share
|
Feb 28
2022 |
|
LXRX
|
Jeffrey L Wade
President and COO |
BUY
Exercise of conversion of derivative security
|
Direct | 66,933 Added 23.37% |
-
|
Feb 28
2022 |
|
LXRX
|
Brian T Crum
SVP, General Counsel & Secr. |
SELL
Payment of exercise price or tax liability
|
Direct | 15,059 Reduced 13.15% |
$42,918
$2.85 p/Share
|
Feb 28
2022 |
|
LXRX
|
Brian T Crum
SVP, General Counsel & Secr. |
BUY
Exercise of conversion of derivative security
|
Direct | 40,880 Added 26.31% |
-
|
Feb 28
2022 |
|
LXRX
|
Kenneth B. Kassler Taub
SVP, Regulatory & QA |
SELL
Payment of exercise price or tax liability
|
Direct | 13,241 Reduced 13.36% |
$37,737
$2.85 p/Share
|
Feb 28
2022 |
|
LXRX
|
Kenneth B. Kassler Taub
SVP, Regulatory & QA |
BUY
Exercise of conversion of derivative security
|
Direct | 36,628 Added 26.99% |
-
|
Feb 28
2022 |
|
LXRX
|
Alan J Main
EVP, Innov & Chem Sciences |
SELL
Payment of exercise price or tax liability
|
Direct | 19,756 Reduced 10.11% |
$56,305
$2.85 p/Share
|
Feb 28
2022 |
|
LXRX
|
Alan J Main
EVP, Innov & Chem Sciences |
BUY
Exercise of conversion of derivative security
|
Direct | 54,650 Added 21.86% |
-
|
Feb 28
2022 |
|
LXRX
|
Kiernan Seth
VP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 8,261 Reduced 27.42% |
$23,544
$2.85 p/Share
|
Feb 28
2022 |
|
LXRX
|
Kiernan Seth
VP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 30,128 Added 50.0% |
-
|
Feb 28
2022 |
|
LXRX
|
Kristen Alexander
VP, Finance and Accounting |
SELL
Payment of exercise price or tax liability
|
Direct | 3,337 Reduced 16.44% |
$9,510
$2.85 p/Share
|
Feb 28
2022 |
|
LXRX
|
Kristen Alexander
VP, Finance and Accounting |
BUY
Exercise of conversion of derivative security
|
Direct | 11,300 Added 35.76% |
-
|
Feb 28
2022 |
|
ECC
|
Thomas P. Majewski
Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct | 995 Reduced 100.0% |
$24,875
$25.0 p/Share
|
Feb 28
2022 |
|
ECC
|
Daniel M. Spinner |
SELL
Other acquisition or disposition
|
Direct | 192 Reduced 100.0% |
$4,800
$25.0 p/Share
|
Feb 28
2022 |
|
UVE
|
Stephen Donaghy
CEO |
BUY
Open market or private purchase
|
Direct | 10,000 Added 1.54% |
$119,000
$11.9 p/Share
|
Feb 28
2022 |
|
BAND
|
Daryl Raiford
Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect | 1,625 Added 50.0% |
$49,969
$30.75 p/Share
|
Feb 28
2022 |
|
BAND
|
Daryl Raiford
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 8,135 Added 50.0% |
$249,989
$30.73 p/Share
|
Feb 28
2022 |
|
BAND
|
Richard Brandon Asbill
General Counsel |
BUY
Open market or private purchase
|
Direct | 3,000 Added 43.18% |
$92,340
$30.78 p/Share
|
Feb 28
2022 |
|
RAPT
|
William Ho
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 5.11% |
$56,370
$18.79 p/Share
|
Feb 28
2022 |
|
HMPT
|
Jr. Phillip R. Shoemaker
President of Originations |
BUY
Exercise of conversion of derivative security
|
Direct | 75,000 Added 20.39% |
$139,500
$1.86 p/Share
|
Feb 28
2022 |